share_log

Unicycive Therapeutics | SC 13G: Statement of acquisition of beneficial ownership by individuals-Logos Global Management LP(9.9%),Logos Global Management GP LLC(9.9%), etc.

SEC announcement ·  Jan 22 00:00
Disclaimer: This content is for informational and educational purposes only and does not constitute a recommendation or endorsement of any specific investment or investment strategy. Read more